New pill tested to tame uncontrollable hives
NCT ID NCT07219615
Summary
This study is testing an oral medication called ritlecitinib to see if it can safely reduce itchy hives and swelling in adults with chronic spontaneous urticaria (CSU) that isn't controlled by standard allergy medicines. About 200 participants will be randomly assigned to take either a 50mg dose, a 100mg dose, or a placebo pill daily for 12 weeks, followed by a 12-week extension period. The main goal is to measure changes in hive and itch activity and monitor for any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC SPONTANEOUS URTICARIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Allergy, Asthma and Clinical Research
NOT_YET_RECRUITINGOklahoma City, Oklahoma, 73120, United States
-
Revival Research Institute, LLC
RECRUITINGTroy, Michigan, 48084, United States
Conditions
Explore the condition pages connected to this study.